Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
CRYOMASS TECHNOLOGIES INC
No one on the platform currently holds CRYM.
No tracked institution reports a position in CRYM as of their last filing.
No one on the platform has traded CRYM yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| CRYMCryomass Technologies Inc. | $0.00 | +0.00% | $47432 | — |
| GENPFGenix Pharmaceuticals Corporation | $0.01 | +0.00% | $844893 | — |
| IGEXIndo Global Exchange(s) PTE, Ltd. | $0.00 | +0.00% | $3M | — |
| KAYSKaya Holdings, Inc. | $0.00 | +0.00% | $4157 | — |
| KOANResonate Blends, Inc. | $0.00 | +0.00% | $78100 | — |
| LVVVLiveWire Ergogenics, Inc. | $0.00 | +0.00% | $761592 | — |
| MCOAMarijuana Company of America, Inc. | $0.00 | +0.00% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry
$CRYM https://www.sec.gov/Archives/edgar/data/1533030/000121390025071346/ea0251713-8k_cryomass.htm
View on StockTwits ↗$CRYM Hey Christian Noel and Dr. Delon Human, when are you guys gonna put the twinkies down and get to work?
View on StockTwits ↗$CRYM anyone know why this is on the expert market instead of OTC now?
View on StockTwits ↗$CRYM https://www.globenewswire.com/news-release/2025/02/26/3032795/0/en/CryoMass-Announces-Sale-of-CryoSift-Separator-and-License-of-Its-Cryogenic-Refinement-Technology-in-Oklahoma-Market.html
View on StockTwits ↗$CRYM any updates lately? Last I can find is from May of last year.
View on StockTwits ↗$CRYM x $LEEEF https://cryomass.com/2024/05/cryomass-partners-with-cannabis-powerhouse-leef-to-deploy-its-cryo-separation-technology/
View on StockTwits ↗$CRYM always pinned until it isn’t 🥱🤫
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.